A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Beijing Cancer Hospital, Beijing

Peking University Third Hospital, Beijing

Shengjing Hospital of China Medical University, Shenyang

The First Hospital of Jilin University, Changchun

Fudan University Shanghai Cancer Center, Shanghai

The First Affiliated Hospital of Soochow University, Suzhou

Anhui Provincial Cancer Hospital, Hefei

Shandong Cancer Hospital, Jinan

Tianjin Medical University Cancer Institute & Hospital, Tianjin

The First Affiliated Hospital of Zhejiang University school of medicine, Hangzhou

The First Affiliated Hospital of Nanchang University, Nanchang

Fujian Medical University Union Hospital, Fuzhou

Chongqing University Cancer Hospital, Chongqing

Henan Cancer Hospital, Zhengzhou

Guangdong Provincial Peoples Hospital, Guangzhou

West China Hospital, Sichuan University, Chengdu